Fifth Third Bancorp
EW icon

Fifth Third Bancorp’s Edwards Lifesciences EW Stock Holding History

Fifth Third Bancorp’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.4M Buy
142,677
+118,867
+499% +$9.8M 0.02% 423
2025
Q4 		$2.03M Sell
23,810
-1,497
-6% -$123K 0.01% 458
2025
Q3 		$1.97M Buy
25,307
+1,437
+6% +$112K 0.01% 473
2025
Q2 		$1.87M Buy
23,870
+1,865
+8% +$139K 0.01% 475
2025
Q1 		$1.59M Sell
22,005
-47
-0.2% -$3.36K 0.01% 484
2024
Q4 		$1.63M Sell
22,052
-563
-2% -$39.4K 0.01% 482
2024
Q3 		$1.49M Sell
22,615
-45,062
-67% -$3.27M 0.01% 525
2024
Q2 		$6.25M Sell
67,677
-2,192
-3% -$194K 0.02% 284
2024
Q1 		$6.68M Buy
69,869
+1,211
+2% +$102K 0.03% 284
2023
Q4 		$5.24M Sell
68,658
-16,389
-19% -$1.14M 0.02% 296
2023
Q3 		$5.89M Sell
85,047
-4,125
-5% -$331K 0.03% 285
2023
Q2 		$8.41M Buy
89,172
+7,275
+9% +$632K 0.04% 258
2023
Q1 		$6.78M Buy
81,897
+3,804
+5% +$299K 0.03% 280
2022
Q4 		$5.83M Sell
78,093
-16,136
-17% -$1.24M 0.03% 302
2022
Q3 		$7.79M Sell
94,229
-1,011
-1% -$97.3K 0.04% 261
2022
Q2 		$9.06M Buy
95,240
+5,437
+6% +$563K 0.04% 256
2022
Q1 		$10.6M Buy
89,803
+549
+0.6% +$61.6K 0.04% 260
2021
Q4 		$11.6M Buy
89,254
+11,540
+15% +$1.35M 0.04% 249
2021
Q3 		$8.8M Buy
77,714
+9,323
+14% +$1.06M 0.04% 272
2021
Q2 		$7.08M Sell
68,391
-103
-0.2% -$9.71K 0.03% 300
2021
Q1 		$5.73M Buy
68,494
+3,339
+5% +$282K 0.03% 327
2020
Q4 		$5.94M Buy
65,155
+15,229
+31% +$1.26M 0.03% 307
2020
Q3 		$3.98M Buy
49,926
+1,223
+3% +$95.4K 0.02% 346
2020
Q2 		$3.37M Buy
48,703
+1,066
+2% +$75.8K 0.02% 354
2020
Q1 		$3M Buy
47,637
+15,399
+48% +$1.11M 0.02% 336
2019
Q4 		$2.51M Buy
32,238
+6,210
+24% +$485K 0.01% 394
2019
Q3 		$1.91M Buy
26,028
+8,082
+45% +$568K 0.01% 411
2019
Q2 		$1.1M Buy
17,946
+7,329
+69% +$443K 0.01% 488
2019
Q1 		$677K Buy
10,617
+591
+6% +$33.7K ﹤0.01% 553
2018
Q4 		$512K Buy
10,026
+537
+6% +$27.2K ﹤0.01% 599
2018
Q3 		$551K Buy
9,489
+576
+6% +$28.2K ﹤0.01% 666
2018
Q2 		$432K Sell
8,913
-2,214
-20% -$103K ﹤0.01% 719
2018
Q1 		$517K Buy
11,127
+3,840
+53% +$167K ﹤0.01% 678
2017
Q4 		$274K Buy
7,287
+525
+8% +$19.3K ﹤0.01% 799
2017
Q3 		$246K Sell
6,762
-930
-12% -$35.5K ﹤0.01% 827
2017
Q2 		$303K Buy
7,692
+345
+5% +$12.6K ﹤0.01% 805
2017
Q1 		$230K Sell
7,347
-17,163
-70% -$537K ﹤0.01% 864
2016
Q4 		$766K Sell
24,510
-3,309
-12% -$107K 0.01% 600
2016
Q3 		$1.12M Buy
27,819
+1,086
+4% +$40.9K 0.01% 518
2016
Q2 		$889K Buy
26,733
+4,875
+22% +$167K 0.01% 551
2016
Q1 		$643K Buy
21,858
+13,884
+174% +$383K 0.01% 646
2015
Q4 		$210K Buy
7,974
+438
+6% +$11.4K ﹤0.01% 946
2015
Q3 		$179K Sell
7,536
-612
-8% -$14.8K ﹤0.01% 989
2015
Q2 		$193K Buy
8,148
+324
+4% +$7.31K ﹤0.01% 1010
2015
Q1 		$186K Sell
7,824
-390
-5% -$8.75K ﹤0.01% 1012
2014
Q4 		$174K Buy
8,214
+2,880
+54% +$57.9K ﹤0.01% 986
2014
Q3 		$91K Buy
5,334
+42
+0.8% +$663 ﹤0.01% 1198
2014
Q2 		$76K Sell
5,292
-48
-0.9% -$651 ﹤0.01% 1268
2014
Q1 		$66K Buy
5,340
+240
+5% +$2.77K ﹤0.01% 1305
2013
Q4 		$56K Buy
5,100
+1,254
+33% +$14.1K ﹤0.01% 1276
2013
Q3 		$45K Sell
3,846
-576
-13% -$6.74K ﹤0.01% 1345
2013
Q2 		$50K Buy
+4,422
New +$52.3K ﹤0.01% 1293

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fifth Third Bancorp's EW Position: Q1 2026 in Review

Fifth Third Bancorp increased its Edwards Lifesciences (EW) stake by 499% in Q1 2026, buying an estimated $9.8M and bringing the position to 142,677 shares worth $11.4M. The position accounts for 0.02% of the portfolio, ranked #423.

Fifth Third Bancorp first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.6M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Fifth Third Bancorp held 142,677 shares of Edwards Lifesciences worth $11.4M as of Q1 2026.
  • Fifth Third Bancorp bought 118,867 Edwards Lifesciences shares in Q1 2026, an estimated $9.8M.
  • Edwards Lifesciences made up 0.02% of Fifth Third Bancorp's portfolio in Q1 2026, its #423 holding.
  • Fifth Third Bancorp first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • Fifth Third Bancorp's Edwards Lifesciences position peaked at $11.6M in Q4 2021.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.